Pulse Brain · Growing Health Evidence Index
Tier 2 — RCT / large cohortPeer-reviewed

Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial

Miroslava Bosheva, István Tokodi, Aleksander Krasnow, Helle Pedersen, Oksana Lukjančenko, Aron C. Eklund, Dominik Grathwohl, Norbert Sprenger, Bernard Berger, Colin I. Cercamondi

Frontiers in Nutrition · 2022

Read source ↗ All evidence

Summary

This multicentre RCT evaluated an infant formula supplemented with a five-component human milk oligosaccharide (HMO) blend in healthy neonates aged 7–21 days, comparing standard formula, two HMO-enriched formulations (1.5 and 2.5 g/L), and a human milk-fed reference group. Infants receiving HMO-supplemented formula developed microbiota compositions and gut maturation markers (higher Bifidobacterium, lower pathogenic Clostridioides difficile, improved immune markers) significantly closer to those of human milk-fed infants, suggesting the specific HMO blend may support healthy intestinal immune development in formula-fed infants.

Regional applicability

The study includes European recruitment sites and uses internationally standardised microbiological and immunological methodologies, making findings broadly applicable to United Kingdom infant nutrition practice. The HMO-supplemented formula approach aligns with established public health interest in closer alignment of formula composition with human milk; however, UK adoption would depend on regulatory approval, cost, and integration with existing infant feeding guidance.

Key measures

Shotgun metagenomics profiling of fecal microbiota; relative abundance of Bifidobacterium longum subsp. infantis and Clostridioides difficile; fecal pH and organic acid profiles; secretory immunoglobulin A (sIgA), alpha-1-antitrypsin, and calprotectin concentrations in fecal samples

Outcomes reported

The study measured gut microbiota composition, bacterial abundance, fecal metabolites, and intestinal biomarkers (sIgA, calprotectin, alpha-1-antitrypsin) in infants fed formula with added human milk oligosaccharides versus standard formula and human milk. Infants receiving HMO-supplemented formula showed microbiota profiles closer to human milk-fed infants, with increased beneficial Bifidobacterium and reduced toxigenic Clostridioides difficile.

Theme
Nutrition & health
Subject
Maternal, infant & child nutrition
Study type
Research
Study design
Randomized controlled trial
Source type
Peer-reviewed study
Status
Published
Geography
International
System type
Human clinical
DOI
10.3389/fnut.2022.920362
Catalogue ID
SNmpyz6e1s-8stckc

Topic tags

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.